Matches in Nanopublications for { ?s ?p "[These findings mechanistically implicate HDAC7 and Nur77 in sensitizing human CTCL cells to panobinostat as well as suggest that cotreatment with an anti-Bcl-2 agent would augment the anti-CTCL activity of panobinostat.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP460933.RAeG_EG2OTRAFKW3v5VtPaK2q4t6jDTvUgGHqOGEoSDjI130_assertion description "[These findings mechanistically implicate HDAC7 and Nur77 in sensitizing human CTCL cells to panobinostat as well as suggest that cotreatment with an anti-Bcl-2 agent would augment the anti-CTCL activity of panobinostat.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP460933.RAeG_EG2OTRAFKW3v5VtPaK2q4t6jDTvUgGHqOGEoSDjI130_provenance.
- NP770674.RA2QMuTEBRlYFkkgxR98mWuwzS0aLFPzn0MrXPL6Ob_mU130_assertion description "[These findings mechanistically implicate HDAC7 and Nur77 in sensitizing human CTCL cells to panobinostat as well as suggest that cotreatment with an anti-Bcl-2 agent would augment the anti-CTCL activity of panobinostat.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP770674.RA2QMuTEBRlYFkkgxR98mWuwzS0aLFPzn0MrXPL6Ob_mU130_provenance.
- NP708582.RANXy9oOkv07UrgKWGGKGTHVt9s4-_VVED3Y-O3DOC2AA130_assertion description "[These findings mechanistically implicate HDAC7 and Nur77 in sensitizing human CTCL cells to panobinostat as well as suggest that cotreatment with an anti-Bcl-2 agent would augment the anti-CTCL activity of panobinostat.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP708582.RANXy9oOkv07UrgKWGGKGTHVt9s4-_VVED3Y-O3DOC2AA130_provenance.